PREDICTORS OF SUSTAINABILITY OF RESPONSE WITH CENOBAMATE: POST-HOC SUBSET ANALYSIS OF A PHASE 3, OPEN-LABEL STUDY

被引：0
|
作者：
Stern, S. [1 ]
Wechsler, R. [2 ,3 ]
Kerr, W. [4 ]
Wade, C. [5 ]
Vossler, D. G. [6 ]
Rosenfeld, W. E. [7 ]
机构：
[1] SK Life Sci Inc, Paramus, NJ USA
[2] Consultants Epilepsy & Neurol, Boise, ID USA
[3] Idaho Comprehens Epilepsy Ctr, Boise, ID USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] SK Life Sci Inc, Sewickley, PA USA
[6] Univ Washington, Sch Med, Seattle, WA USA
[7] Comprehens Epilepsy Care Ctr Children & Adults, St Louis, MO USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO20
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [1] Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study
    Stern, Sean
    Wechsler, Robert
    Kerr, Wesley T.
    Wade, Clarence T.
    Vossler, David G.
    Rosenfeld, William E.
    NEUROLOGY, 2023, 100 (17)
  • [2] Predictors of Achievement of Response With Cenobamate: Post-hoc Subset Analysis From a Phase 3, Open-Label Safety Study
    Wechsler, Robert
    Vossler, David G.
    Kerr, Wesley T.
    Stern, Sean
    Wade, Clarence T.
    Rosenfeld, William E.
    NEUROLOGY, 2023, 100 (17)
  • [3] Efficacy of Cenobamate for Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study
    Sperling, Michael R.
    Abou-Khalil, Bassel
    Aboumatar, Sami
    Bhatia, Perminder
    Biton, Victor
    Klein, Pavel
    Krauss, Gregory L.
    Vossler, David G.
    Wechsler, Robert
    Ferrari, Louis
    Kamin, Marc
    Grall, Mindy
    Rosenfeld, William E.
    NEUROLOGY, 2021, 96 (15)
  • [4] Efficacy of cenobamate by focal seizure subtypes: Post-hoc analysis of a phase 3, multicenter, open-label study
    Rosenfeld, William E.
    Ferrari, Louis
    Kamin, Marc
    EPILEPSY RESEARCH, 2022, 183
  • [5] Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study
    Vossler, David G. G.
    Rosenfeld, William E. E.
    Stern, Sean
    Wade, Clarence T. T.
    Ferrari, Louis
    Kerr, Wesley T. T.
    Wechsler, Robert
    EPILEPSIA, 2023, 64 (10) : 2644 - 2652
  • [6] Concomitant Drug Load Reduction During Adjunctive Cenobamate Therapy: Post-hoc Analysis of a Phase 3, Open-Label Study
    Aboumatar, Sami
    Ferrari, Louis
    Stern, Sean
    Wade, Clarence
    Weingarten, Mindl
    Connor, Gregory S.
    Rosenfeld, William E.
    NEUROLOGY, 2023, 100 (17)
  • [7] Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study
    Aboumatar, Sami
    Ferrari, Louis
    Stern, Sean
    Wade, Clarence T.
    Weingarten, Mindl
    Connor, Gregory S.
    Rosenfeld, William E.
    EPILEPSY RESEARCH, 2024, 200
  • [8] Post-hoc Analysis of the Effects of Dose Reductions of Concomitant Clobazam in a Phase 3, Open-Label Study of Cenobamate for the Treatment of Uncontrolled Focal Seizures
    Abou-Khalil, Bassel
    Ferrari, Louis
    Klein, Pavel
    Kim, Jessica
    Krauss, Gregory L.
    Vossler, David G.
    Sperling, Michael R.
    Rosenfeld, William E.
    NEUROLOGY, 2021, 96 (15)
  • [9] Efficacy of Cenobamate by Concomitant Antiseizure Medications in Patients With Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study
    Klein, Pavel
    Vossler, David G.
    Krauss, Gregory L.
    Sperling, Michael R.
    Kamin, Marc
    Rosenfeld, William E.
    NEUROLOGY, 2021, 96 (15)
  • [10] Dose Adjustments to Concomitant Antiseizure Medications: Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures
    Rosenfeld, William E.
    Abou-Khalil, Bassel
    Aboumatar, Sami
    Bhatia, Perminder
    Biton, Victor
    Klein, Pavel
    Krauss, Gregory L.
    Sperling, Michael R.
    Vossler, David G.
    Wechsler, Robert
    NEUROLOGY, 2021, 96 (15)
12345